(BUD) Anheuser Busch Inbev - Ratings and Ratios

Exchange: NYSE • Country: Belgium • Currency: USD • Type: Common Stock • ISIN: US03524A1088

Beer, Spirits, Canned, Non-Alcoholic

Stock: Brewers
Age 16.6y

MCap 135,984m
Avg Vol 1.64M (106M USD)

Beta 0.210
Volatility 21.31%

EPS (Earnings per Share)

EPS CAGR: -43.00%
EPS Trend: -12.1%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: -15.51%
Rev. Trend: -12.6%

Last SUE: -0.02
Qual. Beats: 0

Dividends

Dividend Yield	1.92%
Yield on Cost 5y	2.05%
Yield CAGR 5y	20.34%
Payout Consistency	90.4%
Payout Ratio	34.2%

Risk via 5d forecast
Volatility	21.3%
Value at Risk 5%th	32.7%
Relative Tail Risk	-6.61%

Reward TTM
Sharpe Ratio	1.47
Alpha	40.37
CAGR/Max DD	0.24

Character TTM
Hurst Exponent	0.563
Beta	0.210
Beta Downside	0.068

Drawdowns 3y
Max DD	31.55%
Mean DD	9.96%
Median DD	9.56%

Description: BUD Anheuser Busch Inbev December 02, 2025

Anheuser-Busch InBev (NYSE:BUD) is a global brewer headquartered in Leuven, Belgium, with a portfolio of roughly 500 brands-including Budweiser, Corona Extra, Stella Artois, and Michelob Ultra-sold across North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific. The company also markets spirits-based ready-to-drink and non-alcoholic beverages.

Key metrics as of FY 2023: revenue of $57 billion, adjusted EBITDA margin of 18 %, and net debt-to-EBITDA of 3.2×, reflecting a balance-sheet still leveraged after the 2022-23 debt-reduction program. Growth is being driven by premiumization (e.g., higher-margin craft and imported brands), a 7 % increase in on-trade volume in emerging markets, and a 4 % rise in e-commerce sales of RTD products, while commodity price volatility and shifting consumer preferences toward low-alcohol options remain material risks.

For a deeper, data-rich analysis of BUD’s valuation dynamics, you might explore the company’s profile on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income: 9.85b TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA 0.77 > 1.0
NWC/Revenue: -11.36% < 20% (prev -39.36%; Δ 28.01% < -1%)
CFO/TA 0.07 > 3% & CFO 15.19b > Net Income 9.85b
Net Debt (61.00b) to EBITDA (24.56b): 2.48 < 3
Current Ratio: 0.70 > 1.5 & < 3
Outstanding Shares: last quarter (1.99b) vs 12m ago -2.79% < -2%
Gross Margin: 55.92% > 18% (prev 0.46%; Δ 5546 % > 0.5%)
Asset Turnover: 41.62% > 50% (prev 34.18%; Δ 7.44% > 0%)
Interest Coverage Ratio: 1.79 > 6 (EBITDA TTM 24.56b / Interest Expense TTM 8.48b)

Altman Z'' 1.61

A: -0.05 (Total Current Assets 23.00b - Total Current Liabilities 33.07b) / Total Assets 206.64b
B: 0.23 (Retained Earnings 46.58b / Total Assets 206.64b)
C: 0.07 (EBIT TTM 15.19b / Avg Total Assets 212.99b)
D: 0.68 (Book Value of Equity 80.67b / Total Liabilities 117.94b)
Altman-Z'' Score: 1.61 = BB

Beneish M -3.09

DSRI: 1.05 (Receivables 5.50b/4.42b, Revenue 88.66b/74.97b)
GMI: 0.82 (GM 55.92% / 45.83%)
AQI: 0.92 (AQ_t 0.77 / AQ_t-1 0.84)
SGI: 1.18 (Revenue 88.66b / 74.97b)
TATA: -0.03 (NI 9.85b - CFO 15.19b) / TA 206.64b)
Beneish M-Score: -3.09 (Cap -4..+1) = AA

ValueRay F-Score (Strict, 0-100) 60.58

1. Piotroski: 6.0pt
2. FCF Yield: 5.80%
3. FCF Margin: 13.14%
4. Debt/Equity: 0.79
5. Debt/Ebitda: 2.48
6. ROIC - WACC: 2.16%
7. RoE: 11.62%
8. Revenue Trend: -12.57%
9. EPS Trend: -12.10%

What is the price of BUD shares?

As of January 27, 2026, the stock is trading at USD 69.40 with a total of 1,278,707 shares traded.
Over the past week, the price has changed by +0.74%, over one month by +8.03%, over three months by +12.83% and over the past year by +41.52%.

Is BUD a buy, sell or hold?

Anheuser Busch Inbev has received a consensus analysts rating of 4.15. Therefore, it is recommended to buy BUD.

Strong Buy: 5
Buy: 5
Hold: 3
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the BUD price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	78.1	12.5%
Analysts Target Price	78.1	12.5%
ValueRay Target Price	73.2	5.5%

BUD Fundamental Data Overview January 27, 2026

P/E Trailing = 23.2159
P/E Forward = 16.6667
P/S = 2.3203
P/B = 1.6846
P/EG = 1.398
Revenue TTM = 88.66b USD
EBIT TTM = 15.19b USD
EBITDA TTM = 24.56b USD
Long Term Debt = 68.97b USD (from longTermDebt, last fiscal year)
Short Term Debt = 1.45b USD (from shortTermDebt, last fiscal year)
Debt = 72.17b USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 61.00b USD (from netDebt column, last fiscal year)
Enterprise Value = 200.78b USD (135.98b + Debt 72.17b - CCE 7.37b)
Interest Coverage Ratio = 1.79 (Ebit TTM 15.19b / Interest Expense TTM 8.48b)
EV/FCF = 17.24x (Enterprise Value 200.78b / FCF TTM 11.65b)
FCF Yield = 5.80% (FCF TTM 11.65b / Enterprise Value 200.78b)
FCF Margin = 13.14% (FCF TTM 11.65b / Revenue TTM 88.66b)
Net Margin = 11.10% (Net Income TTM 9.85b / Revenue TTM 88.66b)
Gross Margin = 55.92% ((Revenue TTM 88.66b - Cost of Revenue TTM 39.08b) / Revenue TTM)
Gross Margin QoQ = 56.41% (prev 56.29%)
Tobins Q-Ratio = 0.97 (Enterprise Value 200.78b / Total Assets 206.64b)
Interest Expense / Debt = 1.25% (Interest Expense 903.0m / Debt 72.17b)
Taxrate = 32.14% (726.0m / 2.26b)
NOPAT = 10.31b (EBIT 15.19b * (1 - 32.14%))
Current Ratio = 0.70 (Total Current Assets 23.00b / Total Current Liabilities 33.07b)
Debt / Equity = 0.79 (Debt 72.17b / totalStockholderEquity, last quarter 91.41b)
Debt / EBITDA = 2.48 (Net Debt 61.00b / EBITDA 24.56b)
Debt / FCF = 5.24 (Net Debt 61.00b / FCF TTM 11.65b)
Total Stockholder Equity = 84.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.62% (Net Income 9.85b / Total Assets 206.64b)
RoE = 11.62% (Net Income TTM 9.85b / Total Stockholder Equity 84.76b)
RoCE = 9.88% (EBIT 15.19b / Capital Employed (Equity 84.76b + L.T.Debt 68.97b))
RoIC = 6.83% (NOPAT 10.31b / Invested Capital 151.01b)
WACC = 4.66% (E(135.98b)/V(208.15b) * Re(6.69%) + D(72.17b)/V(208.15b) * Rd(1.25%) * (1-Tc(0.32)))
Discount Rate = 6.69% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -0.75%
[DCF Debug] Terminal Value 86.31% ; FCFF base≈11.26b ; Y1≈11.23b ; Y5≈11.83b
Fair Price DCF = 169.5 (EV 352.96b - Net Debt 61.00b = Equity 291.97b / Shares 1.72b; r=5.90% [WACC]; 5y FCF grow -0.88% → 2.90% )
EPS Correlation: -12.10 | EPS CAGR: -43.00% | SUE: -4.0 | # QB: 0
Revenue Correlation: -12.57 | Revenue CAGR: -15.51% | SUE: -0.02 | # QB: 0
EPS next Year (2026-12-31): EPS=4.17 | Chg30d=-0.011 | Revisions Net=+0 | Growth EPS=+14.2% | Growth Revenue=+5.7%

Additional Sources for BUD Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle